What's Happening?
The American Hospital Association (AHA) has formally requested that the Medicare Payment Advisory Commission (MedPAC) conduct a thorough examination of Medicare Advantage (MA) plans' utilization management practices. The AHA's concerns stem from reports
that MA plans frequently delay or deny access to medically necessary post-acute care, such as inpatient rehabilitation facilities (IRFs) and long-term care hospitals (LTCHs). MedPAC's own preliminary findings support these concerns, indicating that MA beneficiaries use less post-acute care overall and have longer acute care hospital stays compared to those in fee-for-service (FFS) Medicare. For instance, in 2023, there were 14 IRF stays per 1,000 FFS beneficiaries, but only five per 1,000 for MA enrollees. Similarly, acute care hospital stays for MA beneficiaries discharged to an IRF were nine days, compared to six days for FFS beneficiaries. The AHA highlights that MA plans often attempt to redirect patients to skilled nursing facilities (SNFs) even when a higher level of care is recommended by treating clinicians, and that denial rationales are often incomplete, with reviewers lacking relevant expertise.
Why It's Important?
These practices by Medicare Advantage plans have significant implications for patient care, hospital operations, and the broader healthcare system. Patients may experience interrupted recovery, increased risk of clinical deterioration, and readmission due to delayed or denied access to appropriate post-acute care. This can lead to worse health outcomes and increased burdens on beneficiaries and their families. For hospitals, these delays mean acute care beds are occupied longer, straining capacity and resources needed for other patients. The AHA emphasizes that IRFs, LTCHs, and SNFs are not interchangeable, and steering patients to a lower level of care than prescribed by clinicians is inappropriate. The issue also raises questions about the effectiveness of current oversight mechanisms for MA plans and whether they are adhering to guidelines that require them to follow traditional Medicare coverage criteria for basic benefits.
What's Next?
The AHA recommends that MedPAC continue its analysis by adjusting comparisons for beneficiary characteristics, examining outcomes associated with different post-acute settings (e.g., mortality, readmissions, functional improvement), and analyzing the time between discharge readiness and transfer to post-acute care. They also urge MedPAC to evaluate denial rationales, the qualifications of plan reviewers, and the adequacy of MA post-acute networks. Furthermore, the AHA suggests interviewing various stakeholders, including hospital discharge planners, treating clinicians, post-acute providers, beneficiaries, and family caregivers, to gain a comprehensive understanding of how prior authorization operates in practice. This continued investigation could lead to policy recommendations aimed at strengthening oversight of MA plans and ensuring timely, appropriate access to care for beneficiaries.
Beyond the Headlines
The ongoing debate surrounding Medicare Advantage prior authorization practices touches upon fundamental ethical and systemic issues within the U.S. healthcare landscape. The tension between cost containment strategies employed by MA plans and the clinical judgment of healthcare providers highlights a potential conflict of interest, where financial incentives might influence patient care decisions. This situation could erode trust in the healthcare system and disproportionately affect vulnerable populations who rely on these services. The AHA's call for detailed scrutiny of reviewer expertise and denial processes suggests a need for greater transparency and accountability from MA plans. Ultimately, the outcome of MedPAC's investigation and subsequent policy changes could redefine the balance between managed care efficiency and patient-centered care, potentially influencing the future structure and regulation of Medicare Advantage programs.
